If you join the study, doctors will look at the tissue removed during your surgery to decide if you need more treatment. What the study doctor suggests will depend on your lab results and how far your cancer has spread. You might get no treatment, or you might get less treatment than usual. You will get a chest x-ray and CT scan before the study starts, after the study ends, and during the study if needed. You will have a genetic test to look for changes in your tumor’s DNA. After the study, your study doctor will keep checking on you, watch for any side effects, and track your health. You will have check-up visits at 3 months and 6 months, then every 6 months for 3 years, and once a year until the study ends. You or your insurance will need to pay for the medical care you get during the study. You will not be paid for being in this study.

Who can Participate

You can join this study if you are 18 or older, have early-stage endometrial cancer (Stage I, II, or III), and had surgery to remove your uterus or ovaries in the past 10 weeks, or plan to have it soon. You cannot join if you already had chemotherapy for this cancer, had radiation to your pelvis before, or had other cancers unless they were skin cancer, cervical cancer, or other solid tumors that were treated and cured. To learn more about this study, click the NCT number below to visit ClinicalTrials.gov.

Study ID

More information available at ClinicalTrials.gov: NCT06388018